Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis

E-ISSN： 1873-5592|14|6|676-699

ISSN： 1389-4501

Source： Current Drug Targets, Vol.14, Iss.6, 2013-06, pp. : 676-699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis Drug Targets

Current Drug Targets, Vol. 3, Iss. 2, 2002-04 ,pp. : 131-154

Bentham Science Publishers

Access to resources Recommend Favorite

Aquaporins as Targets for Drug Discovery

Current Pharmaceutical Design, Vol. 13, Iss. 23, 2007-08 ,pp. : 2421-2427

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Tuberculosis Drugs and Drug Targets]

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 2, 2007-06 ,pp. : 71-72

Bentham Science Publishers

Access to resources Recommend Favorite

In Search of Drug Targets for Mycobacterium tuberculosis

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 7, Iss. 3, 2007-09 ,pp. : 245-250

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors

By Sawyer Tomi K

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 1, 2004-01 ,pp. : 1-19

Informa Healthcare

Access to resources Recommend Favorite